New Hematology & Medical Oncology Chief in Sunset Park Named
NYU Langone names Dr. Nina D’Abreo as the chief of the Division of Hematology and Medical Oncology at Perlmutter Cancer Center—Sunset Park.
New Hope for Patients Who Have Lung Cancer
NYU Winthrop Hospital offer immunotherapies for people who have lung cancer.
New Hospital Pavilion with Pediatric Hospital Facility Opens
NYU Langone adds to New York City’s healthcare space with the Helen L. and Martin S. Kimmel Pavilion and Hassenfeld Children’s Hospital.
New Hybrid Treatment Forces Cancer Cells to Starve
An NYU Langone study shows that the combination of a drug and a protein fragment prevents the growth of multiply myeloma cancer cells in mice.
New Imaging Sequences Surface Hard-to-Detect Microadenomas
New Imaging Sequences Surface Hard-to-Detect MicroadenomasWhen microadenomas are correctly identified and localized preoperatively in the pituitary gland, a minimally ...
New Immunotherapy Drug More Effective in Treating Melanoma
NYU Langone study finds that immunotherapy drug nivolumab is superior in efficacy and safety compared to ipilimumab when treating melanoma.
New Immunotherapy Drug Shows Promise Against Several Cancers
A study from NYU Langone’s Perlmutter Cancer Center shows an experimental drug may be effective in treating several types of late-stage cancers.
New Immunotherapy for Treating Advanced Lung Cancer
Dr. Jeffrey G. Schneider, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, discusses a new treatment for advanced lung cancer.
New Inflammatory Syndrome in Children Linked to COVID-19
NYU Langone pediatrician Dr. Adam Ratner discusses what you should know about the emerging inflammatory syndrome seen in children with COVID-19.
New Intraoperative System Correctly Classifies Brain Tumors
Study led by NYU Langone’s Dr. Daniel A. Orringer combines optical imaging with artificial intelligence to diagnose brain tumors in real time.